Publicacións (129) Publicacións nas que participase algún/ha investigador/a

2007

  1. A comprehensive strategy for the subtyping of patients with Fanconi anaemia: Conclusions from the Spanish Fanconi Anemia Research Network

    Journal of Medical Genetics, Vol. 44, Núm. 4, pp. 241-249

  2. A rheumatology consultancy program with general practitioners in Catalonia, Spain

    Journal of Rheumatology, Vol. 34, Núm. 6, pp. 1328-1331

  3. Acute atropine intoxication with psychiatric symptoms by herbal infusion of Pulmonaria officinalis (Lungwort)

    European Journal of Psychiatry, Vol. 21, Núm. 2, pp. 93-97

  4. Adecuación de la admisión desde un servicio de urgencias

    Medicina Preventiva, Vol. 13, Núm. 3, pp. 14-17

  5. Adjunctive treatment with risperidone in clozapine-resistant schizophrenia: A case report and review

    Clinical Neuropharmacology, Vol. 30, Núm. 2, pp. 114-121

  6. Amino acid conservation in the gp41 transmembrane protein and natural polymorphisms associated with enfuvirtide resistance across HIV-1 variants

    AIDS Research and Human Retroviruses, Vol. 23, Núm. 9, pp. 1067-1074

  7. Aspergilosis cutánea primaria en un niño con leucemia

    Actas Dermo-Sifiliograficas, Vol. 98, Núm. 4, pp. 276-278

  8. Auditoría clínica sobre la utilización de la radiografía en el abordaje del traumatismo craneal pediátrico

    Revista de calidad asistencial, Vol. 22, Núm. 5, pp. 249-255

  9. Baseline serum hepatitis C virus (HCV) RNA level and response at week 4 are the best predictors of relapse after treatment with pegylated interferon plus ribavirin in HIV/HCV-coinfected patients

    Journal of Acquired Immune Deficiency Syndromes, Vol. 45, Núm. 4, pp. 439-444

  10. Bayesian network analysis of resistance pathways against HIV-1 protease inhibitors

    Infection, Genetics and Evolution, Vol. 7, Núm. 3, pp. 382-390

  11. Buenas prácticas en gestión sanitaria: el caso Kaiser Permanente

    Revista de administración sanitaria siglo XXI, Vol. 5, Núm. 2, pp. 283-292

  12. CD4+ T cell evolution and predictors of its trend before and after tenofovir/didanosine backbone in the presence of sustained undetectable HIV plasma viral load

    Journal of Antimicrobial Chemotherapy, Vol. 59, Núm. 6, pp. 1141-1147

  13. Care of patients coinfected with HIV and hepatitis C virus: 2007 Updated recommendations from the HCV-HIV International Panel

    AIDS, Vol. 21, Núm. 9, pp. 1073-1089

  14. Changes in the distribution of hepatitis C virus (HCV) genotypes over time in Spain according to HIV serostatus: Implications for HCV therapy in HCV/HIV-coinfected patients

    Journal of Infection, Vol. 54, Núm. 2, pp. 173-179

  15. Changes in the incidence of tuberculosis in a cohort of HIV-seroconverters before and after the introduction of HAART

    AIDS, Vol. 21, Núm. 18, pp. 2521-2527

  16. Changing rates and patterns of drug resistance mutations in antiretroviral-experienced HIV-infected patients

    AIDS Research and Human Retroviruses, Vol. 23, Núm. 7, pp. 879-885

  17. Clearance of hepatitis C virus in HIV-infected patients with multiple chronic viral hepatitis

    Journal of Viral Hepatitis, Vol. 14, Núm. 6, pp. 392-395

  18. Clinical validation of saquinavir/ritonavir genotypic resistance score in protease-inhibitor-experienced patients

    Antiviral Therapy, Vol. 12, Núm. 2, pp. 247-252

  19. Cognitive dimensions in first-episode schizophrenia spectrum disorders

    Journal of Psychiatric Research, Vol. 41, Núm. 11, pp. 968-977

  20. Cognitive dysfunction in first-episode psychosis: The processing speed hypothesis

    British Journal of Psychiatry, Vol. 191, Núm. SUPPL. 51